Results 141 to 150 of about 10,266 (173)

High prevalence of pfmdr1 and pfpm2 amplification and pfmdr1 haplotypes in Plasmodium falciparum isolates circulating in Ghana. [PDF]

open access: yesMalar J
Kassim AR   +15 more
europepmc   +1 more source

Genomic profiling of drug resistance markers in Plasmodium falciparum samples from the Democratic Republic of the Congo (2017) and Tanzania (2020-2021). [PDF]

open access: yesJ Antimicrob Chemother
Khote FL   +12 more
europepmc   +1 more source

Molecular markers of antimalarial drug resistance in pfk13, pfmdr1, pfdhfr, and pfdhps genes of Plasmodium falciparum in a rural municipality in Cubal, Benguela Province, Angola (2022-2023). [PDF]

open access: yesMalar J
Mediavilla A   +15 more
europepmc   +1 more source

Efficacy of artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria among children aged 2-11 years in the Asante Akim North Municipality, Ghana: a single-arm open trial. [PDF]

open access: yesMalar J
Hanson H   +14 more
europepmc   +1 more source

Estimating the changing prevalence of molecular markers of artemisinin partial resistance in Plasmodium falciparum malaria in Sub-Saharan Africa

open access: yes
Harrison LE   +11 more
europepmc   +1 more source

Efficacies of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trial. [PDF]

open access: yesLancet Infect Dis
Kamya MR   +22 more
europepmc   +1 more source

Making the most of existing antimalarial medicines: a single dose cure with sulfadoxine-pyrimethamine plus artesunate-pyronaridine. [PDF]

open access: yesMalar J
Mombo-Ngoma G   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy